• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[良性前列腺增生症患者组织学前列腺炎与前列腺特异性抗原、前列腺体积、前列腺特异抗原密度、国际前列腺症状评分、最大尿流率及残余尿量的相关性]

[Correlation of histological prostatitis with PSA, prostate volume, PSAD, IPSS, Qmax and PVR in BPH patients].

作者信息

Zhang Hong-Tuan, Xu Yong, Chang Ji-Wu, Zhang Zhi-Hong, Liu Ran-Lu, Ma Bao-Jie

机构信息

Department of Urology and Andrology, The Second Hospital of Tianjin Medical University, Tianjin 300211, China.

出版信息

Zhonghua Nan Ke Xue. 2012 Mar;18(3):208-11.

PMID:22474983
Abstract

OBJECTIVE

To explore the correlation of histologically proven prostatitis with the level of prostate specific antigen (PSA), prostate volume, PSA density (PSAD), international prostate symptom score (IPSS), maximum flow rate (Qmax) and post-void residual volume (PVR) in men with symptoms of benign prostate hyperplasia (BPH).

METHODS

Totally 673 patients surgically treated for BPH were divided into Groups A and B in accordance with histological findings, the former including those with histological prostatitis, and the latter without it. Comparisons were made between the two groups in the PSA level, prostate volume, PSAD, IPSS, Qmax and PVR.

RESULTS

The PSA level, prostate volume, IPSS and PVR were significantly higher in Group A ([5.64 +/- 2.48] microg/L, [43.66 +/- 13.11] ml, 24.72 +/- 5.39 and [124.90 +/- 49.80] ml) than in B ([4.97 +/- 1.99] microg/L, [40.41 +/- 11.44] ml, 23.40 +/- 6.21 and [112.73 +/- 50.03] ml) (P<0.05), while Qmax markedly lower in the former ([6.94 +/- 3.23] ml/s) than in the latter ([7.75 +/- 3.52] ml/s) (P<0.05), but PSAD showed no statistically significant difference between the two groups (0.129 +/- 0.048 vs 0.123 +/- 0.034, P>0.05).

CONCLUSION

Histological prostatitis can significantly increase the PSA level, prostate volume, IPSS and PVR, and reduce the Qmax of the patient, but is not correlated with PSAD. It is an important factor influencing the clinical progression of BPH.

摘要

目的

探讨经组织学证实的前列腺炎与良性前列腺增生(BPH)症状男性的前列腺特异性抗原(PSA)水平、前列腺体积、PSA密度(PSAD)、国际前列腺症状评分(IPSS)、最大尿流率(Qmax)及残余尿量(PVR)之间的相关性。

方法

将673例接受BPH手术治疗的患者根据组织学检查结果分为A组和B组,A组为有组织学前列腺炎的患者,B组为无组织学前列腺炎的患者。比较两组患者的PSA水平、前列腺体积、PSAD、IPSS、Qmax及PVR。

结果

A组患者的PSA水平、前列腺体积、IPSS及PVR显著高于B组(分别为[5.64±2.48]μg/L、[43.66±13.11]ml、24.72±5.39及[124.90±49.80]ml,B组分别为[4.97±1.99]μg/L、[40.41±11.44]ml、23.40±6.21及[112.73±50.03]ml)(P<0.05),而A组患者的Qmax显著低于B组(分别为[6.94±3.23]ml/s和[7.75±3.52]ml/s)(P<0.05),但两组患者的PSAD差异无统计学意义(分别为0.129±0.048和0.123±0.034,P>0.05)。

结论

组织学前列腺炎可显著提高患者的PSA水平、前列腺体积、IPSS及PVR,并降低Qmax,但与PSAD无关。它是影响BPH临床进展的重要因素。

相似文献

1
[Correlation of histological prostatitis with PSA, prostate volume, PSAD, IPSS, Qmax and PVR in BPH patients].[良性前列腺增生症患者组织学前列腺炎与前列腺特异性抗原、前列腺体积、前列腺特异抗原密度、国际前列腺症状评分、最大尿流率及残余尿量的相关性]
Zhonghua Nan Ke Xue. 2012 Mar;18(3):208-11.
2
[Aggressiveness and extent of prostatic inflammation relates with serum PSA levels in type IV prostatitis].[IV型前列腺炎中前列腺炎症的侵袭性和范围与血清前列腺特异抗原水平相关]
Zhonghua Nan Ke Xue. 2012 Aug;18(8):710-4.
3
[A comparative study on different doses of cernilton for preventing the clinical progression of benign prostatic hyperplasia].不同剂量舍尼通预防良性前列腺增生临床进展的对比研究
Zhonghua Nan Ke Xue. 2008 Jun;14(6):533-7.
4
Adding Cyclooxygenase-2 inhibitor to alpha blocker for patients with benign prostate hyperplasia and elevated serum prostate specific antigen could not improve prostate biopsy detection rate but improve lower urinary tract symptoms.对于前列腺特异性抗原升高的良性前列腺增生患者,加用环氧化酶-2 抑制剂和α受体阻滞剂不能提高前列腺活检的检出率,但可改善下尿路症状。
Int J Clin Pract. 2013 Dec;67(12):1327-33. doi: 10.1111/ijcp.12220.
5
Significance of histological prostatitis in patients with urinary retention and underlying benign prostatic hyperplasia or adenocarcinoma of the prostate.在患有尿潴留和前列腺良性增生或前列腺腺癌的患者中,组织学前列腺炎的意义。
BJU Int. 2012 Apr;109(8):1194-7. doi: 10.1111/j.1464-410X.2011.10527.x. Epub 2011 Aug 18.
6
[Correlation of serum prostate specific antigen, the volume and the intravesical prostatic protrusion for diagnosing bladder outlet obstruction in patients with benign prostate hyperplasia].[血清前列腺特异性抗原、体积及膀胱内前列腺突入与诊断良性前列腺增生患者膀胱出口梗阻的相关性]
Hell J Nucl Med. 2007 May-Aug;10(2):138-43.
7
Change in International Prostate Symptom Score, prostrate-specific antigen and prostate volume in patients with benign prostatic hyperplasia followed longitudinally.对良性前列腺增生患者的国际前列腺症状评分、前列腺特异性抗原和前列腺体积进行纵向随访观察。
Int J Urol. 2007 Apr;14(4):321-4; discussion 325. doi: 10.1111/j.1442-2042.2007.01596.x.
8
[Expressions of SIgA and alpha 1-AR in benign prostatic hyperplasia combined with chronic prostatitis and their implications].[良性前列腺增生合并慢性前列腺炎中SIgA和α1-AR的表达及其意义]
Zhonghua Nan Ke Xue. 2013 Apr;19(4):315-20.
9
Prevalence of histological prostatitis in men with benign prostatic hyperplasia or adenocarcinoma of the prostate presenting without urinary retention.无尿潴留表现的良性前列腺增生或前列腺腺癌男性患者中组织学前列腺炎的患病率
S Afr J Surg. 2012 Nov 12;50(4):127-30. doi: 10.7196/sajs.1095.
10
[Correlation between TCM syndrome types and clinical symptoms of benign prostatic hyperplasia with chronic prostatitis].良性前列腺增生伴慢性前列腺炎的中医证型与临床症状的相关性
Zhonghua Nan Ke Xue. 2017 Dec;23(12):1111-1115.

引用本文的文献

1
Efficacy and Safety of Transurethral Columnar Balloon Dilation of the Prostate for the Treatment of Benign Prostatic Hyperplasia: A Multicenter Trial.经尿道柱状球囊前列腺扩张术治疗良性前列腺增生症的疗效和安全性:多中心试验。
Comput Math Methods Med. 2022 Jun 9;2022:7881247. doi: 10.1155/2022/7881247. eCollection 2022.